141 related articles for article (PubMed ID: 38051881)
1. Role of pituitary adenylate cyclase-activating polypeptide in peripheral nerve regeneration: a cellular and molecular perspective.
Maugeri G; D'Agata V
Neural Regen Res; 2024 Jul; 19(7):1429-1430. PubMed ID: 38051881
[No Abstract] [Full Text] [Related]
2. Effects of pituitary adenylate cyclase-activating polypeptide on facial nerve recovery in the Guinea pig.
Kimura H; Kawatani M; Ito E; Ishikawa K
Laryngoscope; 2003 Jun; 113(6):1000-6. PubMed ID: 12782812
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenylate cyclase activating polypeptide immunoreactivity in capsaicin-sensitive nerve fibres supplying the rat urinary tract.
Fahrenkrug J; Hannibal J
Neuroscience; 1998 Apr; 83(4):1261-72. PubMed ID: 9502264
[TBL] [Abstract][Full Text] [Related]
4. Pituitary adenylate cyclase activating polypeptide reduces A-type K+ currents and caspase activity in cultured adult mouse olfactory neurons.
Han P; Lucero MT
Neuroscience; 2005; 134(3):745-56. PubMed ID: 16019148
[TBL] [Abstract][Full Text] [Related]
5. Pituitary adenylate cyclase-activating polypeptide: a novel peptide with protean implications.
Pisegna JR; Oh DS
Curr Opin Endocrinol Diabetes Obes; 2007 Feb; 14(1):58-62. PubMed ID: 17940421
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenylate cyclase-activating polypeptide induces period1 and period2 gene expression in the rat suprachiasmatic nucleus during late night.
Nielsen HS; Hannibal J; Knudsen SM; Fahrenkrug J
Neuroscience; 2001; 103(2):433-41. PubMed ID: 11246158
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal pituitary adenylate cyclase activating polypeptide facilitates the spinal nociceptive flexor reflex in the rat.
Xu XJ; Wiesenfeld-Hallin Z
Neuroscience; 1996 Jun; 72(3):801-4. PubMed ID: 9157325
[TBL] [Abstract][Full Text] [Related]
8. Chronic changes in pituitary adenylate cyclase-activating polypeptide and related receptors in response to repeated chemical dural stimulation in rats.
Han X; Ran Y; Su M; Liu Y; Tang W; Dong Z; Yu S
Mol Pain; 2017; 13():1744806917720361. PubMed ID: 28776455
[TBL] [Abstract][Full Text] [Related]
9. Effect of K
Kokoti L; Al-Karagholi MA; Elbahi FA; Coskun H; Ghanizada H; Amin FM; Ashina M
Cephalalgia; 2022 Aug; 42(9):846-858. PubMed ID: 35301859
[TBL] [Abstract][Full Text] [Related]
10. Stage-dependent regulation of ovarian pituitary adenylate cyclase-activating polypeptide mRNA levels by GnRH in cultured rat granulosa cells.
Park JY; Park JH; Park HJ; Lee JY; Lee YI; Lee K; Chun SY
Endocrinology; 2001 Sep; 142(9):3828-35. PubMed ID: 11517159
[TBL] [Abstract][Full Text] [Related]
11. Regulation of pituitary adenylate cyclase activating polypeptide and its receptor type 1 after traumatic brain injury: comparison with brain-derived neurotrophic factor and the induction of neuronal cell death.
Skoglösa Y; Lewén A; Takei N; Hillered L; Lindholm D
Neuroscience; 1999 Apr; 90(1):235-47. PubMed ID: 10188950
[TBL] [Abstract][Full Text] [Related]
12. Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance.
Alexandre D; Vaudry H; Grumolato L; Turquier V; Fournier A; Jégou S; Anouar Y
Endocrinology; 2002 Jul; 143(7):2680-92. PubMed ID: 12072402
[TBL] [Abstract][Full Text] [Related]
13. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
Van Rampelbergh J; Gourlet P; De Neef P; Robberecht P; Waelbroeck M
Mol Pharmacol; 1996 Dec; 50(6):1596-604. PubMed ID: 8967982
[TBL] [Abstract][Full Text] [Related]
14. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
15. Distribution of pituitary adenylate cyclase-activating polypeptide and pituitary adenylate cyclase-activating polypeptide type I receptor mRNA in the chicken brain.
Peeters K; Gerets HH; Arckens L; Vandesande F
J Comp Neurol; 2000 Jul; 423(1):66-82. PubMed ID: 10861537
[TBL] [Abstract][Full Text] [Related]
16. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D
Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase-activating peptide (PACAP) and PACAP type 1 receptor expression in regenerating adult mouse and rat superior cervical ganglia in vitro.
Moller K; Reimer M; Hannibal J; Fahrenkrug J; Sundler F; Kanje M
Brain Res; 1997 Nov; 775(1-2):156-65. PubMed ID: 9439839
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.
Vaudry D; Gonzalez BJ; Basille M; Yon L; Fournier A; Vaudry H
Pharmacol Rev; 2000 Jun; 52(2):269-324. PubMed ID: 10835102
[TBL] [Abstract][Full Text] [Related]
20. [Physiological significance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the nervous system].
Hashimoto H
Yakugaku Zasshi; 2002 Dec; 122(12):1109-21. PubMed ID: 12510388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
